Tumor SOCS3 methylation status predicts the treatment response to TACE and prognosis in HCC patients

BACKGROUND: Suppressor of cytokine signaling (SOCS) 1 and 3 methylation have been associated with clinical features and outcomes of cancer patients. However, their roles in determining the treatment response to transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC) re...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Jiang, Bei-Ge, Wang, Neng, Huang, Jian, Yang, Yuan, Sun, Liang-Liang, Pan, Ze-Ya, Zhou, Wei-Ping
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2017
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5438677/
https://ncbi.nlm.nih.gov/pubmed/28404963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16157
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky